Use of Somatostatin Analogs in Patients With Neuroendocrine Tumors
May 13th 2016Wouter W. de Herder, MD, PhD, professor of Endocrine Oncology, Erasmus MC, discusses the use of somatostatin analogs in patients with neuroendocrine tumors, as well as significant clinical trials investigating these agents.